Hubmacher Laboratory

A novel pathogenic variant was identified in ADAMTS17 in a large family with Weill-Marchesani syndrome (WMS) from Newfoundland, Canada. We could show biochemically that the C1023Y variant prevented ADAMTS17 secretion, which was also described for other pathogenic ADAMTS17 variants and most likely results in a functional null allele.